These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6743052)

  • 21. The aetiology of multiple sclerosis.
    Lancet; 1981 Jun; 1(8234):1347-8. PubMed ID: 6113315
    [No Abstract]   [Full Text] [Related]  

  • 22. The Role of HLA in MS Susceptibility and Phenotype.
    Greer JM
    Curr Top Behav Neurosci; 2015; 26():1-27. PubMed ID: 25502788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA determinants in familial multiple sclerosis.
    Grasso MG; Cutrupi F; Bernardi S; Trabace S; Pozzilli C; Cappellacci S; Fieschi C
    Neuroepidemiology; 1992; 11(2):85-9. PubMed ID: 1495578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine. British & Dutch Multiple Sclerosis Azathioprine Trial Group.
    J Neurol Neurosurg Psychiatry; 1988 Mar; 51(3):412-5. PubMed ID: 3283297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.
    Marrosu MG; Cocco E; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Sardu C; Contu P
    J Neurol; 2006 Feb; 253(2):208-13. PubMed ID: 16096810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HLA antigen study in familial cases of disseminated sclerosis and in twins].
    Zavalishin IA; Tananov AT; Nevskaia OM; Kulov BB
    Vrach Delo; 1984 Aug; (8):91-3. PubMed ID: 6542279
    [No Abstract]   [Full Text] [Related]  

  • 28. A follow-up study of Nordic multiple sclerosis candidate gene regions.
    Datta P; Harbo HF; Ryder LP; Akesson E; Benedikz J; Celius EG; Andersen O; Myhr KM; Sandberg-Wollheim M; Hillert J; Svejgaard A; Sorensen PS; Spurkland A; Oturai A
    Mult Scler; 2007 Jun; 13(5):584-9. PubMed ID: 17548436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunogenetics of multiple sclerosis].
    Clanet M; Cambon-Thomsen A; Rascol A
    Pathol Biol (Paris); 1987 Mar; 35(3):299-302. PubMed ID: 3295695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sclerosis genetics 2010.
    McElroy JP; Oksenberg JR
    Neurol Clin; 2011 May; 29(2):219-31. PubMed ID: 21439438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Family and twin studies in multiple sclerosis.
    McFarland HF; Greenstein J; McFarlin DE; Eldridge R; Xu XH; Krebs H
    Ann N Y Acad Sci; 1984; 436():118-24. PubMed ID: 6398014
    [No Abstract]   [Full Text] [Related]  

  • 32. Factor B alleles and multiple sclerosis.
    Bertrams J
    Lancet; 1982 Jan; 1(8266):288. PubMed ID: 6120306
    [No Abstract]   [Full Text] [Related]  

  • 33. [11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
    Wegener S; Falk U; Lakner K; Meyer-Riennecker HJ; Hauptmann G; Uring-Lambert B
    Beitr Infusionsther; 1992; 30():324-31. PubMed ID: 1284726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic susceptibility to multiple sclerosis.
    Visscher BR; Detels R; Dudley J; Haile RW; Malmgren RM; Terasaki PI; Park MS
    Neurology; 1979 Oct; 29(10):1354-60. PubMed ID: 573379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA alleles modulate EBV viral load in multiple sclerosis.
    Agostini S; Mancuso R; Guerini FR; D'Alfonso S; Agliardi C; Hernis A; Zanzottera M; Barizzone N; Leone MA; Caputo D; Rovaris M; Clerici M
    J Transl Med; 2018 Mar; 16(1):80. PubMed ID: 29587799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA associations with multiple sclerosis in Sicily and Malta.
    Elian M; Alonso A; Awad J; Dean G; Okoye R; Sachs J; Savettieri G; Vassallo L; Festenstein H
    Dis Markers; 1987 Jun; 5(2):89-99. PubMed ID: 3509722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic analysis workshop IV: some clinical, pathological and etiological aspects of two HLA-related diseases.
    Hors J; Deschamps I; Schuller E
    Genet Epidemiol Suppl; 1986; 1():291-7. PubMed ID: 3569860
    [No Abstract]   [Full Text] [Related]  

  • 39. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possible mechanisms for association of HLA antigens and disease.
    Mittal KK
    Prog Clin Biol Res; 1977; 16():39-51. PubMed ID: 198823
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.